Page 168 - Profile's Stock Exchange Handbook - 2026 Issue 3
P. 168
JSE - REM Profile’s Stock Exchange Handbook: 2026 - Issue 3
RATIOS
Remgro Ltd. Ret on SH Fnd 8.57 2.57 1.99 8.88 12.93
Ret On Tot Ass 8.85 4.37 4.82 4.85 9.51
Oper Pft Mgn 7.55 6.17 5.32 4.85 4.91
D:E 0.09 0.09 0.10 0.15 0.21
Current Ratio 3.51 3.74 2.07 1.86 2.31
Div Cover 5.38 1.09 0.85 7.12 15.52
NUMBER OF EMPLOYEES: 173
DIRECTORS: Lubbe M, Malherbe J (ne),
ISIN: ZAE000026480 SHORT: REMGRO CODE: REM Moleketi P J (ind ne), Morobe M M (ind ne),
REG NO: 1968/006415/06 FOUNDED: 2000 LISTED: 2000 Neethling P J (alt), Nieuwoudt G G (ne),
Ramon C (ind ne), Rantloane L (ind ne),
NATURE OF BUSINESS: Rupert A (ne), Vosloo C P (alt), Rupert J P
Originally established in the 1940s by the late Dr Anton (Chair, ne), de Bruyn S E N (Dep Chair, ld ind ne),
Durand J J (CEO), Williams N (CFO)
Rupert, Remgro’s investment portfolio has evolved POSTAL ADDRESS: PO Box 456, Stellenbosch, 7599
substantially since then and currently includes investee Scan the QR code to EMAIL: dh@remgro.com
companies across eight pillars. The Company is listed on visit our website WEBSITE: www.remgro.com
the Johannesburg Stock Exchange (JSE), operated by the TELEPHONE: 021-888-3000
JSE Ltd. in South Africa under the “Financials – Financial COMPANY SECRETARY: Luche Joubert
Services – Investment Banking and Brokerage Services TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
SPONSOR: Rand Merchant Bank (A division of FirstRand Bank Ltd.)
– Diversified Financial Services” sector, with the share AUDITORS: Ernst & Young Inc.
code “REM”. From 3 January 2022, the Company also has BANKERS: First National Bank
a secondary listing on the A2X. Remgro’s interests consist CALENDAR Expected Status
mainly of investments in the healthcare, consumer Next Final Results Sep 2026 Unconfirmed
products, financial services, infrastructure, industrial and Annual General Meeting Nov 2026 Unconfirmed
media industries. Next Interim Results Mar 2027 Unconfirmed
Remgro’s most significant investments are as follows: CAPITAL STRUCTURE Authorised Issued
Mediclinic Group Ltd. (Mediclinic) (50.0% interest), REM Ords no par val 1 000 000 000 529 217 007
OUTsurance Group Ltd. (OUTsurance Group) (30.6% DISTRIBUTIONS [ZARc]
interest), Community Investment Ventures Holdings Ords no par val Ldt Pay Amt
(Pty) Ltd. (CIVH) (57.0% interest), Heineken Beverages Interim No 51 21 Apr 26 28 Apr 26 173.00
Holdings Ltd. (Heineken Beverages) (18.8% interest), RCL Final No 50 21 Oct 25 27 Oct 25 246.70
Foods Ltd. (RCL Foods) (79.9% interest), Rainbow (79.9% Special 21 Oct 25 27 Oct 25 198.95
interest), Discovery Ltd. (Discovery) (7.8% interest), Interim No 49 14 Apr 25 22 Apr 25 95.50
Siqalo Foods (Pty) Ltd. (Siqalo Foods) (100.0% interest), LIQUIDITY: Jun26 Avg 6m shares p.w., R981.0m(54.4% p.a.)
Air Products South Africa (Pty) Ltd. (Air Products) (50.0%
interest), TotalEnergies Marketing South Africa (Pty) Ltd. REMGRO 40 Week MA GENF 22000
(TotalEnergies) (24.9% interest) and Kagiso Tiso Holdings 20000
(Pty) Ltd. (KTH) (43.5% interest). These investments 18000
contribute approximately 88% to Remgro’s intrinsic net 16000
asset value (INAV after tax).
14000
SECTOR: Fins--FinServcs--InvBnkng&BrokerServcs-- DiversFinServcs 12000
MAJOR ORDINARY SHAREHOLDERS as at 30 Jun 2025 10000
Public Investment Commissioner 17.31%
Ninety One SA (Pty) Ltd. 5.10% 2022 2023 2024 2025 2026 8000
Fairtree Asset Management (Pty) Ltd. 5.01%
FINANCIAL STATISTICS RECENT ANNOUNCEMENTS
Dec 25 Jun 25 Jun 24 Jun 23 Jun 22
(R million) Interim Final Final(rst) Final(rst) Final(rst) Friday, 29 May 2026: Remgro released a voluntary
Sales 27 134 51 506 50 424 48 151 41 876 statement containing a summary of Mediclinic’s financial
results for the year ended 31 March 2026. Mediclinic
Op Inc 2 049 3 179 2 683 2 335 2 057 Holdings Ltd. reported a strong operational performance
NetIntPd(Rcvd) - 259 - 341 147 17 499 for the year ended 31 March 2026, despite challenging
Tax 695 957 948 832 757
Minority Int 244 - 117 1 135 1 196 1 840 market conditions. Adjusted revenue increased by
Att Inc 5 168 3 303 1 241 9 624 13 139 11% to USD5.36 billion, driven by volume growth and
TotCompInc/Loss 5 356 6 364 - 205 21 618 13 033 favourable mix changes. Adjusted EBITDA rose by 14%
Hline Erngs-CO 5 175 7 827 5 646 6 642 5 816 to USD842 million, with an EBITDA margin of 15.7%.
Fixed Ass 12 120 12 070 11 052 10 230 17 968 Adjusted earnings grew by 45% to USD345 million. The
Inv in Assoc 65 216 67 132 70 038 75 792 50 771 Group’s net debt remained stable at USD2.27 billion, and
Inv & Loans 23 401 22 449 20 066 22 747 21 047 cash conversion was 106%. A proposed restructuring
Def Tax Asset 284 277 194 176 219 involves Remgro acquiring full ownership of Mediclinic
Tot Curr Ass 35 399 29 438 26 814 23 707 44 478 Southern Africa for USD950 million, and MSC’s IHL
Ord SH Int 119 456 117 039 112 117 115 267 98 443 acquiring Hirslanden for the same amount, leading
Minority Int 6 834 6 840 7 047 6 521 17 437 to the classification of these divisions as discontinued
LT Liab 10 342 10 419 7 030 11 787 21 128
Tot Curr Liab 10 083 7 876 12 984 12 740 19 295 operations. Impairment charges of USD555 million
related to the Hirslanden division were recognised.
PER SHARE STATISTICS (cents per share)
EPS (ZARc) 930.00 591.87 222.82 1 701.02 2 315.77 Wednesday, 22 April 2026: Remgro has disposed of
HEPS-C (ZARc) 931.00 1 401.60 1 012.65 1 173.80 1 025.58 its remaining 39 603 406 FirstRand shares through
Pct chng p.a. 32.8 38.4 - 13.7 14.5 106.0 further on-market transactions, for an aggregate cash
Tr 5yr av grwth % - 42.2 20.8 22.6 20.0 consideration of R3.59 million.
DPS (ZARc) 173.00 541.15 262.61 238.74 149.21 Remgro interim results December 2025 - Wednesday,
Pct chng p.a. - 36.1 106.1 10.0 60.0 70.1 25 March 2026: Revenue for the period went up to
Tr 5yr av grwth % - 38.0 6.8 6.0 - 4.5 R27.134 billion (2024: R26.395 billion) and trading profit
NAV PS (ZARc) 21 481.00 20 944.38 20 097.85 20 641.98 17 360.31 increased to R2.049 billion (2024: R1.987 billion). Net
3 Yr Beta 0.78 0.73 0.55 0.52 0.84 profit for the period attributable to equity holders rose
Price High 18 380 16 412 16 315 14 762 15 096 to R5.168 billion (2024: R3.658 billion). Furthermore,
Price Low 15 681 12 860 11 539 12 143 10 458 headline earnings per share grew to 931 cents per share
Price Prd End 18 161 15 737 13 537 14 628 12 665 (2024: 672 cents per share).
166

